Chromogranins
A group of acidic proteins that are major components of SECRETORY GRANULES in the endocrine and neuroendocrine cells. They play important roles in the aggregation, packaging, sorting, and processing of secretory protein prior to secretion. They are cleaved to release biologically active peptides. There are various types of granins, usually classified by their sources.
Chromogranin B
A type of chromogranin which was initially characterized in a rat PHEOCHROMOCYTOMA CELL LINE. It is found in many species including human, rat, mouse, and others. It is an acidic protein with 626 to 657 amino acid residues. In some species, it inhibits secretion of PARATHYROID HORMONE or INSULIN and exerts bacteriolytic effects in others.
Chromogranin A
A type of chromogranin which was first isolated from CHROMAFFIN CELLS of the ADRENAL MEDULLA but is also found in other tissues and in many species including human, bovine, rat, mouse, and others. It is an acidic protein with 431 to 445 amino acid residues. It contains fragments that inhibit vasoconstriction or release of hormones and neurotransmitter, while other fragments exert antimicrobial actions.
Adrenal Medulla
The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline (EPINEPHRINE) and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM.
Chromaffin Granules
Chromaffin Cells
Cells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia (PARAGANGLIA, CHROMAFFIN) of the sympathetic nervous system.
Calcium Radioisotopes
Secretory Vesicles
Cattle
Calcium
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. (1/462)
The disulfide-bonded loop of chromogranin B (CgB), a regulated secretory protein with widespread distribution in neuroendocrine cells, is known to be essential for the sorting of CgB from the trans-Golgi network (TGN) to immature secretory granules. Here we show that this loop, when fused to the constitutively secreted protein alpha1-antitrypsin (AT), is sufficient to direct the fusion protein to secretory granules. Importantly, the sorting efficiency of the AT reporter protein bearing two loops (E2/3-AT-E2/3) is much higher compared with that of AT with a single disulfide-bonded loop. In contrast to endogenous CgB, E2/3-AT-E2/3 does not undergo Ca2+/pH-dependent aggregation in the TGN. Furthermore, the disulfide-bonded loop of CgB mediates membrane binding in the TGN and does so with 5-fold higher efficiency if two loops are present on the reporter protein. The latter finding supports the concept that under physiological conditions, aggregates of CgB are the sorted units of cargo which have multiple loops on their surface leading to high membrane binding and sorting efficiency of CgB in the TGN. (+info)Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma. (2/462)
Inhibition of angiogenesis has been shown to reduce tumor growth, metastasis, and tumor microvascular density in experimental models. To these effects we would now like to add induction of differentiation, based on biological analysis of xenografted human neuroblastoma (SH-SY5Y, WAG rnu/rnu) treated with the angiogenesis inhibitor TNP-470. Treatment with TNP-470 (10 mg/kg s.c., n = 15) reduced the tumor growth by 66% and stereological vascular parameters (Lv, Vv, Sv) by 36-45%. The tumor cell apoptotic fraction increased more than threefold, resulting in a decrease in viable tumor cells by 33%. In contrast, the mean vascular diameter (29 microm) and the mean tumor cell proliferative index (49%) were unaffected. TNP-470-treated tumors exhibited striking chromaffin differentiation of neuroblastoma cells, observed as increased expression of insulin-like growth factor II gene (+88%), tyrosine hydroxylase (+96%), chromogranin A, and cellular processes. Statistical analysis revealed an inverse correlation between differentiation and angiogenesis. It is suggested that by inhibiting angiogenesis, TNP-470 induces metabolic stress, resulting in chromaffin differentiation and apoptosis in neuroblastoma. Such agonal differentiation may be the link between angiostatic therapy and tumor cell apoptosis. (+info)Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model. (3/462)
It was previously shown in the PC-295 xenograft that the number of chromogranin A (CgA)-positive neuroendocrine (NE) cells increased after androgen withdrawal. NE cells did not proliferate and differentiated from G0-phase-arrested cells. Here we further characterized NE differentiation, androgen receptor status, and apoptosis-associated Bcl-2 expression in the PC-295 model after androgen withdrawal to assess the origin of NE cells. PC-295 tumor volumes decreased by 50% in 4 days. Intraperitoneal bromodeoxyuridine (BrdU) incorporation and MIB-1 labeling decreased to 0%, and the apoptosis was maximal at day 4. Androgen receptor expression and prostate-specific antigen (PSA) serum levels decreased rapidly within 2 days. The number of NE cells increased 6-fold at day 4 and 30-fold at day 7. Five and ten percent of the CgA-positive cells were BrdU positive after continuous BrdU labeling for 2 and 4 days, respectively. However, no MIB-1 expression was observed in CgA-positive cells. NE cells expressed the regulated secretory pathway marker secretogranin III but were negative for androgen receptor and Bcl-2. Bcl-2 expression did increase in the non-NE tumor cells. In conclusion, androgen withdrawal leads to a rapid PC-295 tumor regression and a proliferation-independent induction of NE differentiation. The strictly androgen-independent NE cells that were still present after 21 days differentiated mainly from G0-phase-arrested cells. (+info)Islet amyloid polypeptide/amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation. (4/462)
OBJECTIVE: Islet amyloid polypeptide (IAPP), also named amylin, is the predominant protein component of amyloid deposits in human islet beta cell tumours of the pancreas (insulinomas). IAPP is co-produced with insulin by islet beta cells. We investigated IAPP expression in relation to insulin expression and to amyloid formation in eleven insulinomas. DESIGN AND METHODS: RNA and protein extracts were prepared from the same pieces of tumour tissue, and from specimens of two normal human pancreata. IAPP and insulin mRNA and peptide content were quantified using Northern blot analysis and radioimmunoassay (RIA) respectively. Molecular forms of IAPP immunoreactivity were analysed by reversed-phase high-performance liquid chromatography (HPLC). The presence of islet hormones and of amyloid was assessed by (immuno)histochemical staining of paraffin sections. Plasma levels of IAPP and insulin prior to tumour resection were determined by RIA. RESULTS: IAPP and insulin mRNA and peptide content varied widely between the tumour specimens, and there was considerable intratumour heterogeneity of peptide content. HPLC analysis indicated correct proteolytic processing of the IAPP precursor protein. Amyloid deposits were detected only in the three tumours with the highest IAPP content. In contrast to insulin, plasma levels of IAPP were not elevated in the insulinoma patients. CONCLUSIONS: The spectrum of hormone production by insulinomas cannot be inferred from only a few tissue sections due to intratumour heterogeneity. Expression of the IAPP and insulin genes is not coupled in insulinomas, which produce properly processed mature IAPP. In addition to IAPP overproduction, additional factors such as intracellular accumulation of IAPP are involved in amyloidogenesis in insulinomas. (+info)Library of sequence-specific radioimmunoassays for human chromogranin A. (5/462)
BACKGROUND: Human chromogranin A (CgA) is an acidic protein widely expressed in neuroendocrine tissue and tumors. The extensive tissue- and tumor-specific cleavages of CgA at basic cleavage sites produce multiple peptides. METHODS: We have developed a library of RIAs specific for different epitopes, including the NH2 and COOH termini and three sequences adjacent to dibasic sites in the remaining part of CgA. RESULTS: The antisera raised against CgA(210-222) and CgA(340-348) required a free NH2 terminus for binding. All antisera displayed high titers, high indexes of heterogeneity ( approximately 1.0), and high binding affinities (Keff0 approximately 0.1 x 10(12) to 1.0 x 10(12) L/mol), implying that the RIAs were monospecific and sensitive. The concentration of CgA in different tissues varied with the assay used. Hence, in a carcinoid tumor the concentration varied from 0.5 to 34.0 nmol/g tissue depending on the specificity of the CgA assay. The lowest concentration in all tumors was measured with the assay specific for the NH2 terminus of CgA. This is consistent with the relatively low concentrations measured in plasma from carcinoid tumor patients by the N-terminal assay, whereas the assays using antisera raised against CgA(210-222) and CgA(340-348) measured increased concentrations. CONCLUSION: Only some CgA assays appear useful for diagnosis of neuroendocrine tumors, but the entire library is valuable for studies of the expression and processing of human CgA. (+info)Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. (6/462)
BACKGROUND: Serum chromogranin A (CgA) is regarded as a reliable marker of neuroendocrine proliferation. We previously described increased serum CgA levels during short-term profound gastric acid inhibition. AIM: To investigate serum gastrin and CgA levels in dyspeptic patients during continuous medium- (6 weeks to 1 year), or long-term (1-8 years) gastric acid suppressive therapy. PATIENTS AND METHODS: 114 consecutive dyspeptic patients referred for upper gastrointestinal endoscopy were enrolled in a cross-sectional, case-control study [62 patients on continuous antisecretory therapy, either with proton pump inhibitors (n = 47) or H2-receptor antagonists (H2RA) (n = 15) for gastro-oesophageal reflux disease with or without Barrett's oesophagus or functional dyspepsia, and 52 age- and sex-matched patients without medical acid inhibition and with normal endoscopic findings (control group)]. Omeprazole doses ranged from 20 mg to 80 mg daily and ranitidine from 150 mg to 450 mg daily. Fasting serum CgA and serum gastrin levels were measured by radioimmunoassay (reference values: serum CgA < 4.0 nmol/L; serum gastrin < 85 ng/L). RESULTS: Fasting serum CgA levels positively correlated with serum gastrin in the entire study population (r = 0. 55, P = 0.0001). Median serum CgA values were higher in patients treated with a proton pump inhibitor than H2RA [2.8 (2.0-5.9) nmol/L vs. 2 (1.9-2.3) nmol/L, P < 0.002] and controls [2.8 (2.0-5.9) nmol/L vs. 1.8 (1.5-2.2) nmol/L, P < 0.0001) and did not differ between patients treated with H2RA or controls. Serum gastrin and CgA levels in patients on proton pump inhibitor therapy positively correlated with the degree and duration of acid inhibition. Patients on long-term proton pump inhibitor therapy had significantly higher fasting serum gastrin and CgA than those on medium-term proton pump inhibitor therapy [127 (73-217) ng/L vs. 49 (29-78) ng/L, P < 0.0001 and 4.8 (2.8-8) ng/L vs. 2.1 (1.9-2.6) ng/L, P < 0.001]. No such relation was found in patients on medium- vs. long-term H2RA. Overall, patients with positive Helicobacter pylori serology had higher serum gastrin and CgA levels than those with negative H. pylori serology [51 (27-119) ng/L vs. 27 (14-79) ng/L, P = 0.01, 2.4 (1.9-3.4) nmol/L vs. 2.0 (1.7-2.5) nmol/L, P = 0.05]. CONCLUSIONS: During long-term continuous proton pump inhibitor treatment, serum gastrin and CgA levels are significantly elevated compared to H2RA treatment and nontreated dyspeptic controls. H. pylori infection seems to affect gastric ECL cell secretory function. Increased serum CgA values during long-term profound gastric acid inhibition could reflect either gastric enterochromaffin-like cell hyperfunction or proliferative changes. (+info)Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. (7/462)
BACKGROUND: Type 1 gastric carcinoids are associated with hypergastrinaemia and chronic atrophic gastritis, type 2 occur in patients with multiple endocrine neoplasia type 1 combined with Zollinger-Ellison syndrome, and type 3 lack any relation to hypergastrinaemia. Type 1 tumours are usually benign whereas type 3 are highly malignant. AIMS: To identify possible tumour markers in patients with gastric carcinoids. PATIENTS/METHOD: Nine patients with type 1, one with type 2, and five with type 3 were evaluated with regard to symptoms, hormone profile, and prognosis. RESULTS: Plasma chromogranin A was increased in all patients but was higher (p < 0.01) in those with type 3 than those with type 1 carcinoids. All patients with type 3 carcinoids died from metastatic disease, but none of the type 1 patients died as a result of their tumours. One type 1 patient with a solitary liver metastasis received interferon alpha and octreotide treatment. Nine months later, the metastasis was no longer detectable. She is still alive eight years after diagnosis, without recurrent disease. This represents the only reported case of foregut carcinoid with an unresectable liver metastasis that seems to be have been cured by biotherapy. CONCLUSIONS: Plasma chromogranin A appears to be a valuable tumour marker for all types of gastric carcinoid. Combination therapy with interferon alpha and octreotide may be beneficial in patients with metastasising type 1 gastric carcinoids. (+info)Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. (8/462)
Dimethylbenzanthracene (DMBA) induces pancreatic adenocarcinomas in rats 9 months after carcinogen exposure, with precursor lesions (tubular complexes) developing 1 month after initiation of treatment. Because previous studies have suggested an acinar cell of origin for these tumors, we investigated the expression pattern of ductal, acinar, and islet cell markers in these cancers to gain insight into their phenotype and cell of origin. Pancreatic neoplasms were induced in rats by implantation of DMBA into the head of the pancreas. Lesions studied included 10 early tubular complexes (DMBA for 2 weeks), 8 tubular complexes (DMBA for 1 month), and 10 adenocarcinomas (DMBA for 9 months). Normal rat pancreas served as a control. For comparison, 5 human ductal adenocarcinomas were also evaluated. Immunohistochemistry with ductal (keratin, cytokeratin 19, cytokeratin 20), acinar (chymotrypsin), and islet (chromogranin A) cell markers was performed to analyze the tissues. Rat tubular complexes and adenocarcinomas revealed strong expression of keratin, cytokeratin 19, and cytokeratin 20 in the cytoplasm of all neoplastic cells, absence of chymotrypsin, and rare immunoreactivity to chromogranin A. Human adenocarcinomas showed strong expression of keratin and cytokeratin 19 in all neoplastic cells, expression of cytokeratin 20 in 5-20% of cells, and absence of chymotrypsin and chromogranin A. Pancreatic adenocarcinomas induced by DMBA in rats express markers consistent with a ductal phenotype, as observed in human tumors. Ductal marker expression in early tumor stages suggests a ductal cell of origin. (+info)
Secretogranin III ELISA Kits | Biocompare.com
JCI -
A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma
Catecholamine release-inhibitory peptide catestatin (chromogranin A352-372) : Naturally occurring amino acid variant Gly364Ser...
Naturally Occurring Human Genetic Variation in the 3′-Untranslated Region of the Secretory Protein Chromogranin A Is Associated...
Chromogranin A. Storage and release in hypertension. | Hypertension
The bovine chromogranin A gene: structural basis for hormone regulation and generation of biologically active peptides. -...
Common Functional Genetic Variants in Catecholamine Storage Vesicle Protein Promoter Motifs Interact to Trigger Systemic...
Catecholamine Release-Inhibitory Peptide Catestatin (Chromogranin A352-372) | Circulation
PLOS ONE: accelerating the publication of peer-reviewed science
Qiu-Xing Jiang | Hauptman-Woodward Medical Research Institute
WikiGenes - SCG2 - secretogranin II
RefEx - Search Result
CHGB - Secretogranin-1 precursor - Homo sapiens (Human) - CHGB gene & protein
SCG2 Gene - GeneCards | SCG2 Protein | SCG2 Antibody
SCG5 Protein Human Recombinant | Secretogranin V | ProSpec
PANCREASTATIN BINDING-SITES AND ACTION IN INTACT AND PERMEABILIZED RINM5F CELLS<...
I-PRO Mechanics High Capacity - FETAHOVIĆ d.o.o. Zenica
Epson C2800 Black High Capacity (C13S051161)
Outback Power Inc. - EnergyCell Nano-Carbon High Capacity
配件 CO<sub>2</sub> Regulator, inlet fitting meets CGA...
Immunohistochemical Studies of Chromogranins (A and C) in Pituitary Adenomas<...
Autonomic function in hypertension; role of genetic variation at the catecholamine storage vesicle protein chromogranin B
Pancreastatin, a chromogranin A-derived peptide, activates Galpha(16) and phospholipase C-beta(2) by interacting with specific...
Sorting and storage during secretory granule biogenesis: looking backward and looking forward | Biochemical Journal
Chromogranin B | ALZFORUM
Aggregator | pharmamatrix.ca
Glycosylated Chromogranin A in Heart Failure: Implications for Processing and Cardiomyocyte Calcium Homeostasis. | Passport
CHGB Gene - GeneCards | SCG1 Protein | SCG1 Antibody
OriGene - CHGB (NM 001819) Human ORF cDNA Clone
Microtubule-dependent transport of secretory vesicles visualized in real time with a GFP-tagged secretory protein | Journal of...
Neuroendocrine differentiation in a case of cervical cancer
Chromaffin cell | anatomy | Britannica
2018 AACC
Chromogranin A: Reference Range, Interpretation, Collection and Panels
answers
Complex Renal Traits: Role of Adrenergic Genetic Polymorphism | American Society of Nephrology
ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells. - Oxford Neuroscience
An Isolated Abnormal Chromogranin B Is Associated with Pancreato-Duodenal NETs and the Presence of Liver Metastases
Neuroscientists Studying Chemicals that Talk to Other Cells - June 11, 2001
JCI -
Autoreactive T cells in type 1 diabetes
Human CGa clia kit | biobool.com
Reactome | Cd55 [secretory granule membrane]
Reactome | VAMP2 [secretory granule membrane]
GlyConnect
Membranes of chromaffin granules. Isolation and partial characterization of two proteins | Biochemical Journal
Plus it
Binswangers disease, CT scan - Stock Image C001/7913 - Science Photo Library
Plus it
Two proteins associated with secretory granule membranes identified in chicken regulated secretory cells | Journal of Cell...
Plus it
EGF Prevents the Neuroendocrine Differentiation of LNCaP Cells - Page 21
EGF Prevents the Neuroendocrine Differentiation of LNCaP Cells - Page 37
Research Reveals Nutrients Impact on ... ( Vitamin A-derived retinoic acid helps...)
Plus it
FPCNS - Overview: Pancreastatin, Serum
Factbox NET Cancer - INCA
3M™ CeQUINBORD CGA Inorganic Insulating Board | 3M United States
IMP: Integrative Multi-species Prediction
Synaptophysin抗体[SP15]|Abcam中国|Anti-Synaptophysin抗体[SP15]
Chromogranin A
In humans, chromogranin A protein is encoded by the CHGA gene. Examples of cells producing chromogranin A (ChgA) are chromaffin ... Chromogranin A is cleaved by an endogenous prohormone convertase to produce several peptide fragments. See chromogranin A ... Stridsberg M, Angeletti RH, Helle KB (June 2000). "Characterisation of N-terminal chromogranin A and chromogranin B in mammals ... Chromogranin A or parathyroid secretory protein 1 (gene name CHGA) is a member of the granin family of neuroendocrine secretory ...
SCG5
Taupenot L, Harper KL, O'Connor DT (March 2003). "The chromogranin-secretogranin family". The New England Journal of Medicine. ... Lloyd RV, Jin L (March 1994). "Analysis of chromogranin/secretogranin messenger RNAs in human pituitary adenomas". Diagnostic ...
SCG3
Hosaka M, Watanabe T, Sakai Y, Uchiyama Y, Takeuchi T (October 2002). "Identification of a chromogranin A domain that mediates ... The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. ... "Entrez Gene: SCG3 secretogranin III". Huttner WB, Gerdes HH, Rosa P (January 1991). "The granin (chromogranin/secretogranin) ... "Secretogranin III binds to cholesterol in the secretory granule membrane as an adapter for chromogranin A". The Journal of ...
Granin
Chromogranins and secretogranins together share a C-terminal motif, whereas chromogranins A and B share a region of high ... chromogranin A (CgA) chromogranin B (CgB) secretogranin II (SgII) (see also secretoneurin) secretogranin III (SgIII) ... Stridsberg M, Angeletti RH, Helle KB (June 2000). "Characterisation of N-terminal chromogranin A and chromogranin B in mammals ... Granins (chromogranins or secretogranins) are acidic proteins and are present in the secretory granules of a wide variety of ...
SCG2
2000). "Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human ... Chromogranin Kirchmair R, Gander R, Egger M, et al. (2004). "The neuropeptide secretoneurin acts as a direct angiogenic ... SCG2, also called secretogranin II (chromogranin C), is a protein which in humans is encoded by the SCG2 gene. The protein ... 2009). "Chromogranin peptides in amyotrophic lateral sclerosis". Regul. Pept. 152 (1-3): 13-21. doi:10.1016/j.regpep.2008.07. ...
Pheochromocytoma
If metanephrine values are equivocal, chromogranin A can be used as an adjunct marker to predict the presence of a tumor.[ ... Other additional biomarkers can be helpful to aid in the diagnosis of pheochromocytoma as well, most notable is Chromogranin A ... d'Herbomez M, Do Cao C, Vezzosi D, Borzon-Chasot F, Baudin E (September 2010). "Chromogranin A assay in clinical practice". ... However, a 2006 report from Italy found that over 90% of studied pheochromocytoma patients demonstrated elevated chromogranin A ...
Carcinoid syndrome
Chromogranin A and platelets serotonin are increased.[clarification needed] Transthoracic echocardiogram shows valve thickening ... Nobels FR, Kwekkeboom DJ, Bouillon R, Lamberts SW (June 1998). "Chromogranin A: its clinical value as marker of neuroendocrine ... Markers of the condition such as chromogranin-A are imperfect indicators of disease progression. Prognosis varies from ...
Homeostasis
Koeslag, Johan H.; Saunders, Peter T.; Wessels, Jabus A. (1999). "The chromogranins and counter-regulatory hormones: do they ...
Neuroendocrine tumor
Aside from the hormones of secretory tumors, the most important markers are: chromogranin A (CgA), present in 99% of metastatic ... Neuroendocrine secretory protein-55, a member of the chromogranin family, is seen in pancreatic endocrine tumors but not ... Widely used neuroendocrine tissue markers are various chromogranins, synaptophysin and PGP9.5. Neuron-specific enolase (NSE) is ... chromogranin A, and neurotensin do not cause a clinical syndrome, although blood levels may be elevated. Functional tumors are ...
Solid pseudopapillary tumour
... they are negative for chromogranin and pancreatic enzymes. The gold standard for diagnosing solid pseudopapillary tumour of the ...
Secretoneurin
Stridsberg M, Oberg K, Li Q, Engström U, Lundqvist G (January 1995). "Measurements of chromogranin A, chromogranin B ( ... Secretoneurin, is a 33-amino acid neuropeptide derived from secretogranin II (chromogranin C, CHGC). It is cleaved into the ... Tasiemski A, Hammad H, Vandenbulcke F, Breton C, Bilfinger TJ, Pestel J, Salzet M (July 2002). "Presence of chromogranin- ... Portela-Gomes GM, Stridsberg M, Johansson H, Grimelius L (June 1997). "Complex co-localization of chromogranins and ...
Ceruminous adenoma
The cells are negative with chromogranin, synaptophysin and CK20. The major diagnosis from which to separate ceruminous adenoma ...
Saliva testing
Soell M, Feki A, Hannig M, Sano H, Pinget M, Selimovic D (February 2010). "Chromogranin A detection in saliva of type 2 ... chromogranin A) was over-expressed in 100% of diabetic patients when compared to controls. In 2010 Qvarnstrom, et al., ...
Thyroid neoplasm
Intrathyroidal parathyroid adenoma expressing chromogranin A (f) and PTH (g). Calcitonin-negative medullary thyroid carcinoma ( ...
Peptide YY
"Developmental profile of chromogranin, hormonal peptides, and 5-hydroxytryptamine in gastrointestinal endocrine cells". ...
Insulinoma
Pancreatic insulinoma Pancreatic insulinoma Chromogranin A Insulin immuostain Causes of hypoglycemia Metastatic Insulinoma ...
Lung cancer
... or chromogranin. Around 10% of lung cancers are rarer types rather than the classical four. These include mixes of the above ...
Secretogranin-1
... , also known as Chromogranin B, is a protein that in humans is encoded by the CHGB gene. It is a member of the ...
B3GAT1
Jirásek T, Hozák P, Mandys V (2003). "Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal ... conditions that it is of less use in distinguishing these tumours from others than more specific markers such as chromogranin ...
MIA PaCa-2
... chromogranin A, synaptophysin, SSTR2, and NTR1, but not CD56. The cells have a round, epithelial morphology, and are adherent ...
Mepartricin
Fan S, Hao ZY, Zhang L, Chen XG, Zhou J, Zang YF, Tai S, Liang CZ (2014). "Increased chromogranin A and neuron-specific enolase ...
Pancreatic neuroendocrine tumor
... chromogranin A, and neurotensin, do not cause a clinical syndrome although blood levels may be elevated. In total, 85% of ... immunohistochemistry is generally positive for chromogranin and synaptophysin. Genetic testing thereof typically shows altered ...
Synaptophysin
Diagnostically, it is often used in combination with chromogranin A. List of human genes Synaptophysin has been shown to ...
Molecular diagnostics
"Selective localization of the parathyroid secretory protein-I/adrenal medulla chromogranin A protein family in a wide variety ...
Zollinger-Ellison syndrome
An increased level of chromogranin A is a common marker of neuroendocrine tumors. In addition, the source of the increased ...
Neuroendocrine differentiation
Chromogranin A, which is the most abundant product of prostatic neuroendocrine cells and neuroendocrine tumor cells, is widely ... chromogranin A (CgA), synaptophysin and neuron-specific enolase (NSE) (three proteins that are used as markers for ... chromogranin A, synaptophysin, neuron-specific enolase, calcitonin and bombesin/gastrin-releasing peptide, while lacking, or ...
Paraganglioma
... the chief cells located in the cell balls are positive for chromogranin, synaptophysin, neuron specific enolase, serotonin, ...
Nerve tissue protein
Agrin Chimerin Proteins Chromogranins Dopamine and cAMP-Regulated Phosphoprotein 32 Fragile X Mental Retardation Protein GAP-43 ...
Neuroendocrine cell
... chromogranin A, gastrin-releasing peptide (GRP), and cholecystokinin. These cells can be the source of several types of lung ...
Xenin
... is a peptide hormone secreted from the chromogranin A-positive enteroendocrine cells called the K-cells in the mucous ...
Anti-Chromogranin A antibody (ab45179) | Abcam
Rabbit polyclonal Chromogranin A antibody. Validated in WB, IHC, ICC/IF and tested in Mouse, Rat, Human. Cited in 20 ... Anti-Chromogranin A antibody (ab45179) at 1/1000 dilution (purified) + PC-12 cell lysate at 20 µg. Secondary. Goat Anti-Rabbit ... Anti-Chromogranin A antibody (ab45179) at 1/5000 dilution (purified) + SH-SY5Y cell lysate at 10 µg. Secondary. Goat Anti- ... Anti-Chromogranin A antibody (ab45179) at 1/10000 dilution (unpurified) + PC-12 cell lysate at 10 µg. Secondary. HRP-conjugated ...
Circulating Gastrin and Chromogranin A: Elevated | GreenMedInfo
Adverse Pharmacological Actions : Circulating Gastrin and Chromogranin A: Elevated, Tumor Marker Elevation: Chromogranin ... Circulating Gastrin and Chromogranin A: Elevated Related Articles. Medical Errors Kill Enough People to Fill 4 Jumbo Jets a ... 1 Abstracts with Circulating Gastrin and Chromogranin A: Elevated Research. Filter by Study Type. Human Study. ... 1 Problem Substances Researched for Circulating Gastrin and Chromogranin A: Elevated Name. AC. CK. Focus. ...
CHGA Protein Human | Chromogranin A Recombinant | ProSpec
Chromogranin A in the mammalian heart - Resultat
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological...
We report on a cohort of 1170 cases that synaptophysin, chromogranin and CD56 are commonly expressed in ADC and SqCC and that ... The least common positive marker was chromogranin. A combination of ≤2 neuroendocrine markers was positive in 2-3% of ADC and 0 ... All cases were stained with synaptophysin, chromogranin and CD56. Positivity was defined as > 1% positive tumor cells. Data ... Therefore, we investigated retrospectively a large cohort to expand the data on the role of synaptophysin, chromogranin and ...
Chromogranin A Test Uk - Consortium for Post-Genome Science
Chromogranin A Test Uk. Lab Reagents Chromogranin Assay Laboratories manufactures the chromogranin a test uk reagents ... please contact chromogranin assay. Other Chromogranin products are available in stock. Specificity: Chromogranin Category: A ... The Chromogranin A Test Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase ...
An antibody against secretogranin I (chromogranin B) is packaged into secretory granules. | Journal of Cell Biology |...
An antibody against secretogranin I (chromogranin B) is packaged into secretory granules. P Rosa, P Rosa ... P Rosa, U Weiss, R Pepperkok, W Ansorge, C Niehrs, E H Stelzer, W B Huttner; An antibody against secretogranin I (chromogranin ... An mAb against secretogranin I (chromogranin B), a secretory protein costored with various peptide hormones and neuropeptides ...
Chromo Granin A - Metro Office Supply at J. Craig Venter Institute
CHROMOGRANIN IHC | Vijaya Medical Centre
No. 14G, Chinagadili, Health City, Visakhapatnam 530 040, AP, India. [email protected] ...
IMSEAR at SEARO: Salivary chromogranin A as a measure of stress response to noise.
Salivary chromogranin A as a measure of stress response to noise.. Authors: Miyakawa, Masamitsu. Matsui, Toshihito. Kishikawa, ... Miyakawa M, Matsui T, Kishikawa H, Murayama R, Uchiyama I, Itoh T, Yoshida T. Salivary chromogranin A as a measure of stress ... Effects of noise on the secretion of salivary chromogranin A (CgA), which is considered to be a substitute measure of ...
Anti Human Chromogranin A Antibody | Bio-Rad
... recognizes human chromogranin A, a secreted peptide that inhibits glucose-induced insulin release. Chromogranin A is an ... Sheep anti Human Chromogranin A. Product Type. Polyclonal Antibody. Isotype. Polyclonal IgG. Specificity. Chromogranin A. Quick ... Sheep anti Human Chromogranin antibodyrecognizes human chromogranin A, a secreted peptide that inhibits glucose-induced insulin ... Chromogranin A is an activator of microglia (Taupenaut et al. 1996) and is notably upregulated and prominantly expressed in the ...
Enzyme-Linked Immunosorbent Assay for Chromogranin A
- ILVO
Dillen L, De Block J, Van Laer L, De Potter W. Enzyme-Linked Immunosorbent Assay for Chromogranin A. Clinical Chemistry. 1989; ... Dillen, L., De Block, J., Van Laer, L., & De Potter, W. (1989). Enzyme-Linked Immunosorbent Assay for Chromogranin A. Clinical ... Dillen, L, De Block, J, Van Laer, L & De Potter, W 1989, Enzyme-Linked Immunosorbent Assay for Chromogranin A, Clinical ... Enzyme-Linked Immunosorbent Assay for Chromogranin A. / Dillen, Lieve; De Block, Jan; Van Laer, Lutgard ; De Potter, Werner. ...
Chromogranin A (CgA) - Ronny Allan - Living with Neuroendocrine Cancer
... which release chromogranin A and certain hormones into the blood. Chromogranin A may be found in higher than normal amounts in ... Chromogranin A is a type of tumour marker. Also called CgA. Also used in Immunostains where it is specific but not sensitive ... Measuring the amount of chromogranin A in the blood may help to diagnose cancer or other conditions or find out how well ... Tag: Chromogranin A (CgA). A protein found inside neuroendocrine cells, which release chromogranin A and certain hormones into ...
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
... SPADARO, Aldo;AJELLO, Antonino;MORACE, ... High serum levels of chromogranin-A (CgA) have recently been reported in HCC. Impaired hepatic, renal, and heart functions ... High serum levels of chromogranin-A (CgA) have recently been reported in HCC. Impaired hepatic, renal, and heart functions ...
Assisted reproductive technologies do not enhance the variability of DNA methylation imprints in human
Chromogranin 49 Ngl. Using The Cisbio Cga-Elisa-Us Kit. - Gel electrophoresis
... please contact chromogranin elisa. Other Chromogranin products are available in stock. Specificity: Chromogranin Category: 49 ... Chromogranin Elisa Laboratories manufactures the chromogranin 49 ngl. using the cisbio cga-elisa-us kit. reagents distributed ... The Chromogranin 49 Ngl. Using The Cisbio Cga-Elisa-Us Kit. reagent is RUO (Research Use Only) to test human serum or cell ... Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF660R conjugate, Concentration: 0.1mg/mL ...
USCN life science : Producing ELISA kit, ELISA Kit for Guinea Pig Chromogranin A(CHGA)
Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients - CROSBI
Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients}, keyword = {chromogranin A, osteolysis, prostate ... Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients}, keyword = {chromogranin A, osteolysis, prostate ... Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients // Anticancer Research, 24 (2004), 5D. (podatak o ... Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients // Anticancer Research, 24 (2004), 5D. (podatak o ...
Carcinoid syndrome: MedlinePlus Medical Encyclopedia
Merkel Cell Tumors of the Head and Neck: Overview, Pathophysiology and Etiology, Clinical Features
Merkel cells and MCCs have similar neuroendocrine markers, such as neuron-specific enolase, chromogranin, and synaptophysin. ... Osmiophilic granules contain neuropeptide, such as neuron-specific enolase, chromogranins, and synaptophysin. Evidence suggests ... and chromogranin. CK19 expression is increased in tumors positive for the Merkel cell polyomavirus and may help in diagnosis of ...
Mouse Transforming growth factor-beta-induced protein ig-h3 (TGFBI) ELISA kit | CSB-EL023450MO | Cusabio
Lung neuroendocrine tumors: A systematic literature review (Review)
In general, LNETs are positive for chromogranin A, synaptophysin and CD56. However, in types of LNETs that have to be ... Immunologic markers used to differentiate NETs are chromogranin A, synaptophysin, CD56 and NSE. In order to discriminate ... Using this they observed that a low level of 5-HIAA and an increased serum chromogranin A represent an indicator of poor ... the most important tool is the serum dosing of chromogranin A in association with urinary dosing of 5 hydroxyindoleacetic acid ...
Merkel Cell Tumors of the Head and Neck: Overview, Pathophysiology and Etiology, Clinical Features
Merkel cells and MCCs have similar neuroendocrine markers, such as neuron-specific enolase, chromogranin, and synaptophysin. ... Osmiophilic granules contain neuropeptide, such as neuron-specific enolase, chromogranins, and synaptophysin. Evidence suggests ... and chromogranin. CK19 expression is increased in tumors positive for the Merkel cell polyomavirus and may help in diagnosis of ...
Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA...
Chromogranin A (CgA) and its derived peptides have revealed themselves as novel cardiovascular modulators. In humans, normal ... Chromogranin A (CgA) and its derived peptides have revealed themselves as novel cardiovascular modulators. In humans, normal ... Recent data have shown on the unstimulated rat heart that human recombinant Vasostatin-1 (hrVS-1) and rat chromogranin A 1-64 ( ... Recent data have shown on the unstimulated rat heart that human recombinant Vasostatin-1 (hrVS-1) and rat chromogranin A 1-64 ( ...
Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments...
Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments ... Chromogranin/secretogranins are a family of acidic, soluble proteins with a widespread distribution in secretory vesicles of ... The effects of experimental stimuli of differing duration and intensity on chromogranin B and secretogranin II mRNA levels in ... Chromogranins.genetics. Genetic Markers. Male. Molecular Sequence Data. Nerve Tissue Proteins.genetics. Neurons.metabolism. ...
Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen...
T1 - Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific ... Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen ... Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen ... Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen ...
Clinical Chemistry and Laboratory Medicine (CCLM) Volume 36 Issue 11
Using chromogranin A at a cut-off level of 30.3 U/ml it was possible to discriminate between patients in remission and patients ... In our study that lasted over one year we could clearly show that the measurement of chromogranin A is impressively superior to ... Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours ... It is well known that peptide-producing endocrine tumours cosecrete immunoreactive chromogranin A with their characteristic ...
Synaptophysin2
- Merkel cells and MCCs have similar neuroendocrine markers, such as neuron-specific enolase, chromogranin, and synaptophysin. (medscape.com)
- Immunohistochemically, the tumor cells are positive for chromogranin, synaptophysin and neuron-specific enolase. (cap.org)
Secretogranin6
- Chromogranin-A Isoform 1 Preproprotein or CHGA is part of the neuroendocrine secretory proteins of the chromogranin/secretogranin family. (prospecbio.com)
- An antibody against secretogranin I (chromogranin B) is packaged into secretory granules. (rupress.org)
- An mAb against secretogranin I (chromogranin B), a secretory protein costored with various peptide hormones and neuropeptides in secretory granules of many endocrine cells and neurons, was expressed by microinjection of its mRNA into the secretogranin I-producing cell line PC12. (rupress.org)
- The effects of experimental stimuli of differing duration and intensity on chromogranin B and secretogranin II mRNA levels in relevant areas of the rat brain were examined by in situ hybridization histochemistry using 35S-labelled oligonucleotides. (austin.org.au)
- Markedly increased levels of secretogranin II (125-160% of control) and chromogranin B (140-230% of control) mRNA were observed in granule cells of the dentate gyrus 0.5-2 h after amygdaloid stimulation-induced seizures. (austin.org.au)
- These results indicate that measurement of changes in chromogranin mRNA, particularly secretogranin II, is a useful means of assessing both rapid and long-lasting increases and decreases in neuronal activity and, in contrast to immediate early gene mRNA levels, may better reflect specific changes in neuronal secretory activity associated with transmitter/peptide release. (austin.org.au)
Antibody1
- Sheep anti Human Chromogranin antibody recognizes human chromogranin A, a secreted peptide that inhibits glucose-induced insulin release. (bio-rad-antibodies.com)
Peptide4
- It is well known that peptide-producing endocrine tumours cosecrete immunoreactive chromogranin A with their characteristic hormones. (degruyter.com)
- The potent PACAP/vasoactive intestinal peptide (VIP) type I receptor antagonist PACAP6-38 impaired both chromogranin A transcription or catecholamine secretion triggered by PACAP38, while the PACAP/VIP type II receptor antagonist (p-Chloro-D-Phe6, Leu17)-VIP had little or no ability to antagonize the PACAP38 effect. (jci.org)
- Catestatin, an endogenous peptide derived from bovine chromogranin A, and its active domain cateslytin display powerful antimicrobial activities. (uib.no)
- Peptide microarrays for the characterization of antigenic regions of human chromogranin A. (genomeweb.com)
Serum4
- The Chromogranin A Test Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. (postgenomeconsortium.com)
- Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. (unime.it)
- High serum levels of chromogranin-A (CgA) have recently been reported in HCC. (unime.it)
- Plasma androgen receptor and serum chromogranin A in advanced prostate cancer. (cdc.gov)
Antigen1
- Staining of paraffin embedded human pancreas with Sheep anti Human Chromogranin A ( 2095-0220 ) following pronase antigen retrieval. (bio-rad-antibodies.com)
Gastrin1
- Chronic PPI use resulted in significant increases in CGA (including the tumor marker chromogranin A) and significant increases in gastrin compared to controls. (greenmedinfo.com)
Recombinant1
- Recent data have shown on the unstimulated rat heart that human recombinant Vasostatin-1 (hrVS-1) and rat chromogranin A 1-64 (rCgA(1-64)) induce negative inotropic and lusitropic effects counteracting the beta-adrenergic-dependent positive inotropism with a functional noncompetitive antagonism. (unisr.it)
Proteins2
- Chromogranin/secretogranins are a family of acidic, soluble proteins with a widespread distribution in secretory vesicles of endocrine and nervous tissues. (austin.org.au)
- For example, chromogranin A (CgA) and chromogranin B (CgB), two of the major proteins inside secretory vesicles, aggregate because of pH- and Ca 2+ -dependent conformational changes ( Yoo and Lewis, 1996 ). (jneurosci.org)
Secretion4
- Effects of noise on the secretion of salivary chromogranin A (CgA), which is considered to be a substitute measure of catecholamines, were investigated in a laboratory experiment. (who.int)
- Since chromogranin A is secreted along with catecholamines, we asked whether PACAP regulates expression of the chromogranin A gene in PC12 rat chromaffin cells, so as to resynthesize the just-secreted protein, and whether such biosynthetic regulation is coupled mechanistically to catecholamine secretion. (jci.org)
- Thus, PACAP-evoked chromogranin A transcription and catecholamine secretion are likely mediated by the PACAP/VIP type I receptor isoform. (jci.org)
- Although the calcium channel antagonists Zn2+ (100 microM), nifedipine (10 microM), or ruthenium red (10 microM), or the cytosolic calcium chelator BAPTA-AM (50 microM) each strongly impaired PACAP-induced secretion, transcriptional activation of chromogranin A remained unaltered. (jci.org)
Specificity2
- Specificity: Chromogranin Category: 49 Group: Ngl. (electroforese.com)
- Using chromogranin A at a cut-off level of 30.3 U/ml it was possible to discriminate between patients in remission and patients suffering a relapse with a sensitivity of 91.7% and a specificity of 96.4 %, which may be of important diagnostic value. (degruyter.com)
Secretory vesicles1
- Chromogranin A is the major soluble core component in secretory vesicles. (jci.org)
Neuroendocrine4
- A protein found inside neuroendocrine cells, which release chromogranin A and certain hormones into the blood. (ronnyallan.net)
- Chromogranin A may be found in higher than normal amounts in patients with certain neuroendocrine tumours, small cell lung cancer, prostate cancer, and other conditions. (ronnyallan.net)
- Tumour Markers GeneralFor some years the gold standard tumour marker for Neuroendocrine Neoplasms (NENs) has been and remains today, Chromogranin A (and for certain scenarios Chromogranin B and C can provide some additional clues). (ronnyallan.net)
- Increases in intragastric pH may result in hypergastrinemia and enterochromaffin-like cell hyperplasia and increased chromogranin A levels which may interfere with diagnostic investigations for neuroendocrine tumors. (nih.gov)
Salivary2
- IMSEAR at SEARO: Salivary chromogranin A as a measure of stress response to noise. (who.int)
- Salivary Amylase (AA) and Chromogranin A (CgA) are promising biomarkers that can help in the diagnosis of these mental disorders, promoting a better prognosis for the worker. (bvsalud.org)
Prostate cancer2
- Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients // Anticancer Research, 24 (2004), 5D. (irb.hr)
- Introduction: We ascertained whether plasma chromogranin A enhances the power of serology assessing prostate cancer (PC). (unicatt.it)
Bovine1
- Using immunocytochemistry techniques, we demonstrated specific immunostaining with antibodies rose against fragment (547-560) and (614-626) of bovine chromogranin B (CGB) at the level of brain and the tegument of the leech Theromyzon tessulatum. (nel.edu)
Reagents1
- Chromogranin Assay Laboratories manufactures the chromogranin a test uk reagents distributed by Genprice. (postgenomeconsortium.com)
Endogenous1
- PACAP activated the endogenous chromogranin A gene by four- to fivefold. (jci.org)
Marker3
- Chromogranin A is a type of tumour marker. (ronnyallan.net)
- Pancreastatin, which is actually a molecule of Chromogranin A, is another marker touted but appears to be limited to USA. (ronnyallan.net)
- Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments including seizures, osmotic stimulation and axotomy in the rat. (austin.org.au)
Measurement1
- In our study that lasted over one year we could clearly show that the measurement of chromogranin A is impressively superior to 5-hydroxyindoleacetic-acid for detecting a relapse of carcinoids. (degruyter.com)
Laboratories1
- Chromogranin Elisa Laboratories manufactures the chromogranin 49 ngl. (electroforese.com)
Peptides3
- Chromogranin A (CgA) and its derived peptides have revealed themselves as novel cardiovascular modulators. (unisr.it)
- Cellular localization of a chromogranin B -like derived peptides in leeches. (nel.edu)
- Salzet M, Verger-Bocquet M. Cellular localization of a chromogranin B -like derived peptides in leeches. (nel.edu)
Protein1
- Cotransfection of expression plasmids encoding the protein kinase A inhibitor, or an inactive protein kinase A (PKA) catalytic beta subunit, inhibited both forskolin and PACAP activation of chromogranin A transcription, revealing that PACAP-induced trans-activation is highly dependent on PKA. (jci.org)
Markedly1
- Expression of a dominant-negative mutant (KCREB) of the CRE-binding factor CREB markedly diminished trans-activation of the chromogranin A promoter by PACAP. (jci.org)
Chemistry1
- Enzyme-Linked Immunosorbent Assay for Chromogranin A . Clinical Chemistry , 35 , 1934-1938. (ilvo.be)
Levels1
- In plasma samples the levels of chromogranin A (CgA) were also assayed. (unicatt.it)
Studies1
- See more studies on Chromogranin A and. (naturalnews.com)
Blood1
- Measuring the amount of chromogranin A in the blood may help to diagnose cancer or other conditions or find out how well treatment is working or if cancer has come back. (ronnyallan.net)
Products1
- Other Chromogranin products are available in stock. (postgenomeconsortium.com)
Mouse1
- Proportional results (seven- to eightfold activation) were obtained with a transfected 1,200-bp mouse chromogranin A promoter/luciferase reporter construct. (jci.org)
Response2
- A series of chromogranin A promoter 5' deletion mutant/luciferase reporter constructs narrowed down the PACAP response element to a proximal region containing the cAMP response element (CRE box), at (-71 bp)5'-TGACGTAA-3'(-64 bp). (jci.org)
- Thus, the proximal CRE box is entirely necessary for the chromogranin A promoter response to PACAP. (jci.org)
Major1
- Chromogranin A, PIINP, S100A12, Hyaluronic acid - Cisbio leverages its expertise to develop unique immunoassays for major pathologies not covered by conventional biomarkers. (cisbio.eu)